Result of AGM

Fulcrum Pharma PLC
18 December 2006





For immediate release                                          18 December 2006

                               FULCRUM PHARMA PLC
                         ('the Group' or 'the Company')


                             ANNUAL GENERAL MEETING

Fulcrum Pharma plc (AIM: FUL), the drug development and strategic outsourcing
services company, today held its Annual General Meeting at which all of the
resolutions put to shareholders were duly passed.

Fulcrum's Chairman, Prof. Sir Charles George, said: 'Following our Annual
General Meeting today we are pleased to report that trading is in line with
expectations.'

For further information, please contact:

Fulcrum Pharma PLC                             Tel: [phone]
Jon Court, Chief Executive

Notes for editors

About Fulcrum Pharma plc

Fulcrum Pharma plc is an independent, drug development company that is the first
to offer global virtual drug development and strategic outsourcing services to
the pharmaceutical industry. The Group has expertise in the design, execution
and delivery of drug development programmes and relies on state of the art
information technology and infrastructure in the supply of its services.

Through Fulcrum's services to its clients, the Directors believe that there is
the capacity to deliver products faster and more efficiently to the global
pharmaceutical market. Fulcrum does this by using its skills in the design of
drug programmes that deliver the necessary information for decision-making and
product registration. In so doing, Fulcrum works closely with its clients to
meet their strategic R&D goals.

Fulcrum Pharma is listed on the Alternative Investment Market of the London
Stock Exchange having successfully floated in March 2000.




                      This information is provided by RNS
            The company news service from the London Stock Exchange